Cargando…

Hepatoprotective Effect of Cranberry Nutraceutical Extract in Non-alcoholic Fatty Liver Model in Rats: Impact on Insulin Resistance and Nrf-2 Expression

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a pathological accumulation of triglycerides (TGs) in the hepatocyte in the absence of alcohol intake. Untreated NAFLD is expected to progress into liver fibrosis. Cranberry is rich in polyphenols with antioxidant and anti-inflammatory activit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faheem, Safaa A., Saeed, Noha M., El-Naga, Reem N., Ayoub, Iriny M., Azab, Samar S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093716/ https://www.ncbi.nlm.nih.gov/pubmed/32256346 http://dx.doi.org/10.3389/fphar.2020.00218

Ejemplares similares

Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease
por: Zhu, Shenghu, et al.
Publicado: (2020)

Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation
por: Ning, De-Shan, et al.
Publicado: (2022)

Editorial: Angiogenesis and Nutraceuticals
por: Trabalzini, Lorenza, et al.
Publicado: (2022)

Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics
por: Feng, Yanbo, et al.
Publicado: (2021)

A Multifaceted Review of Eurycoma longifolia Nutraceutical Bioactives: Production, Extraction, and Analysis in Drugs and Biofluids
por: Farag, Mohamed A., et al.
Publicado: (2022)

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals
por: Ramadan, Nehal M., et al.
Publicado: (2023)

Nutraceuticals in cognitive impairment and Alzheimer’s disease
por: Mecocci, P., et al.
Publicado: (2014)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
por: Sciarra, Tommaso, et al.
Publicado: (2019)

Safety Profile of Nutraceuticals Rich in Coumarins: An Update
por: Heghes, Simona Codruta, et al.
Publicado: (2022)

Hepatoprotective and Anti-Oxidative Effects of Total Flavonoids From Qu Zhi Qiao (Fruit of Citrus Paradisi cv.Changshanhuyou) on Nonalcoholic Steatohepatitis In Vivo and In Vitro Through Nrf2-ARE Signaling Pathway
por: Shi, Zheng, et al.
Publicado: (2020)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)

Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
por: Li, Mengzhen, et al.
Publicado: (2022)

Literature review on hepatoprotective effects of diosgenin: possible mechanisms of action
por: Mohseni-Moghaddam, Parvaneh, et al.
Publicado: (2023)

Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer
por: Ramírez-Rico, Gerardo, et al.
Publicado: (2022)

Editorial: The role of mushrooms and their nutraceuticals for chronic and degenerative diseases
por: Rai, Sachchida Nand, et al.
Publicado: (2022)

Editorial: Nutraceuticals modulation for oxidative stress in disease and health
por: Chin, Kok-Yong, et al.
Publicado: (2023)

Syzygium aqueum: A Polyphenol- Rich Leaf Extract Exhibits Antioxidant, Hepatoprotective, Pain-Killing and Anti-inflammatory Activities in Animal Models
por: Sobeh, Mansour, et al.
Publicado: (2018)

Cranberries
Publicado: (1870)

Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
por: Mu, Wan, et al.
Publicado: (2019)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

Hepatoprotective Effect and Chemical Assessment of a Selected Egyptian Chickpea Cultivar
por: Mekky, Reham H., et al.
Publicado: (2016)

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018)

Steroidal Alkaloids as an Emerging Therapeutic Alternative for Investigation of Their Immunosuppressive and Hepatoprotective Potential
por: Jan, Naeem U., et al.
Publicado: (2017)

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
por: Chen, Xiao-Feng, et al.
Publicado: (2022)

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
por: Shan, Dan, et al.
Publicado: (2023)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
por: Bortolotti, Massimo, et al.
Publicado: (2019)

Polyphenolic Nutraceuticals to Combat Oxidative Stress Through Microbiota Modulation
por: Vamanu, Emanuel
Publicado: (2019)

Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
por: Spisni, Enzo, et al.
Publicado: (2022)

Editorial: Nutraceuticals: New perspectives and approaches in human health and disease
por: Rosa, Luigi, et al.
Publicado: (2022)

P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway
por: An, Jing, et al.
Publicado: (2021)

Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation
por: Biao, Yaning, et al.
Publicado: (2022)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

Hepatoprotective potential of a novel quinazoline derivative in thioacetamide-induced liver toxicity
por: Salama, Suzy, et al.
Publicado: (2022)

Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)

Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
por: Dehelean, Cristina Adriana, et al.
Publicado: (2022)

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents
por: Weh, Katherine M., et al.
Publicado: (2016)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3a8c5s4opimcck6a1d51ujc6eb